Coloplast A/S (CLPBY)
7.19
+0.02
(+0.28%)
USD |
OTCM |
Oct 28, 16:00
Coloplast Enterprise Value : 18.43B for Oct. 28, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 28, 2026 | 18.43B |
| October 27, 2026 | 18.38B |
| October 26, 2026 | 18.55B |
| October 23, 2026 | 18.72B |
| October 22, 2026 | 18.53B |
| October 21, 2026 | 18.24B |
| October 20, 2026 | 18.43B |
| October 19, 2026 | 18.15B |
| October 16, 2026 | 18.20B |
| October 15, 2026 | 18.11B |
| October 14, 2026 | 17.78B |
| October 13, 2026 | 17.89B |
| October 12, 2026 | 17.47B |
| October 09, 2026 | 17.20B |
| October 08, 2026 | 16.91B |
| October 07, 2026 | 16.81B |
| October 06, 2026 | 16.68B |
| October 05, 2026 | 16.43B |
| October 02, 2026 | 16.33B |
| October 01, 2026 | 16.50B |
| September 30, 2026 | 16.62B |
| September 29, 2026 | 16.81B |
| September 28, 2026 | 16.89B |
| September 25, 2026 | 16.91B |
| September 24, 2026 | 16.87B |
| Date | Value |
|---|---|
| September 23, 2026 | 16.83B |
| September 22, 2026 | 16.91B |
| September 21, 2026 | 16.93B |
| September 18, 2026 | 16.89B |
| September 17, 2026 | 17.02B |
| September 16, 2026 | 16.89B |
| September 15, 2026 | 17.04B |
| September 14, 2026 | 17.10B |
| September 11, 2026 | 17.14B |
| September 10, 2026 | 17.51B |
| September 09, 2026 | 17.49B |
| September 08, 2026 | 17.97B |
| September 04, 2026 | 18.22B |
| September 03, 2026 | 18.61B |
| September 02, 2026 | 18.86B |
| September 01, 2026 | 18.63B |
| August 31, 2026 | 18.32B |
| August 28, 2026 | 18.38B |
| August 27, 2026 | 18.36B |
| August 26, 2026 | 18.32B |
| August 25, 2026 | 18.57B |
| August 24, 2026 | 18.53B |
| August 21, 2026 | 17.78B |
| August 20, 2026 | 17.62B |
| August 19, 2026 | 17.99B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ambu A/S | 3.079B |
| Abbott Laboratories | 205.26B |
| AngioDynamics, Inc. | 491.37M |
| Alphatec Holdings, Inc. | 2.257B |
| AtriCure, Inc. | 3.030B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 227.46M |
| Revenue (Quarterly) | 1.144B |
| Total Expenses (Quarterly) | 916.84M |
| EPS Diluted (Quarterly) | 0.1009 |
| Gross Profit Margin (Quarterly) | 66.73% |
| Profit Margin (Quarterly) | 19.88% |
| Earnings Yield | 2.65% |
| Operating Earnings Yield | 7.19% |
| Normalized Earnings Yield | 4.793 |